$A Cost-effectiveness Analysis of Brentuximab Vedotin in Relapsed or Refractory Systemic Anaplastic Large Cell Lymphoma$

A Cost-effectiveness Analysis of Brentuximab Vedotin in Relapsed or Refractory Systemic Anaplastic Large Cell Lymphoma

**Objective:** To evaluate the cost-effectiveness of brentuximab vedotin in patients with R/R sALCL from a UK NHS perspective. **Methods:** A partitioned survival model used clinical outcomes for brentuximab vedotin from the pivotal phase-2 single-arm trial of brentuximab vedotin in 58 patients wit...

Full description

Saved in:

Bibliographic Details
Main Authors:	Margaret Hux, Denise Zou, Esprit Ma, Peter Sajosi, Andreas Engstrom, Ross Selby, Eugene Benson, Andrew Briggs, Vijayveer Bonthapally
Format:	Article
Language:	English
Published:	Columbia Data Analytics, LLC 2016-10-01
Series:	Journal of Health Economics and Outcomes Research
Online Access:	https://doi.org/10.36469/9820
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Impact of prior CAR T-cell therapy on mosunetuzumab efficacy in patients with relapsed or refractory B-cell lymphomas
by: Elise A. Chong, et al.
Published: (2025-02-01)

Refractory and relapsing forms of <i>Clostridium difficile</i>-associated colitis
by: A. A. Sheptulin
Published: (2011-03-01)

The clinical journey of belantamab mafodotin in relapsed or refractory multiple myeloma: lessons in drug development
by: Pralay Mukhopadhyay, et al.
Published: (2025-02-01)

Cost-effectiveness Analysis of Lorlatinib in Patients Previously Treated with Anaplastic Lymphoma Kinase Inhibitors for Non-small Cell Lung Cancer in Greece
by: George Gourzoulidis, et al.
Published: (2022-02-01)

PI3Kδ inhibitor linperlisib combined with gemcitabine and oxaliplatin for relapsed or refractory diffuse large B-cell lymphoma: a multicenter, single-arm phase Ib/II trial
by: Peng Sun, et al.
Published: (2025-02-01)

Is CAR T a drug or a therapeutic pathway? Intention to treat versus per protocol analysis of real world studies of CAR-T cell therapy in relapsed refractory diffuse large B cell lymphoma
by: Rossana Di Staso, et al.
Published: (2024-11-01)

Venetoclax added to CLAG regimen might improve the outcome of patients with relapsed/refractory acute myeloid leukemia
by: Yu Zhang, et al.
Published: (2025-02-01)

Cost drivers associated with autologous stem-cell transplant (ASCT) in patients with relapsed/refractory diffuse large B-cell lymphoma in a Japanese real-world setting: A structural equation model (SEM) analysis 2012-2022.
by: Saaya Tsutsué, et al.
Published: (2025-01-01)

Advanced NGS analysis of cell-free tumor DNA supports clonal relation to primary high-grade B-cell lymphoma lesion and CNS relapse despite MRI negativity
by: Veronika Navrkalova, et al.
Published: (2025-02-01)

Matching-Adjusted Indirect Comparison of the Efficacy and Safety of Erdafitinib vs Enfortumab Vedotin in Patients with Locally Advanced Metastatic Urothelial Carcinoma
by: Suzy Van Sanden, et al.
Published: (2024-08-01)

Efficacy of rifaximin in the treatment of chronic relapsing diverticulitis
by: S. I. Achkasov, et al.
Published: (2012-04-01)

A remarkable and durable response to tislelizumab treatment of an anaplastic thyroid carcinoma without targetable genomic alterations: a case report
by: Jingjing Chai, et al.
Published: (2025-02-01)

Repeated gastroscopies at impendent relapse of bleeding from gastroduodenal ulcers
by: V. A. Stupin, et al.
Published: (2011-12-01)

Review of Interventional Therapies for Refractory Pediatric Migraine
by: Jacquelin Peck, et al.
Published: (2023-01-01)

Transjugular Portosystemic Shunting in Refractory Cirrhotic Ascites
by: Yu. V. Khoronko, et al.
Published: (2021-04-01)

An Appendix Origin Burkitt’s Lymphoma Spreading into Genital Tract
by: Mustafa Ulubay, et al.
Published: (2015-04-01)

MALT-lymphoma of the stomach: clinical presentation, diagnostics and treatment
by: Ye. V. Ledin, et al.
Published: (2011-02-01)

Advances in the Application of New Ultrasound Technology for the Diagnosis and Treatment of Lymphoma
by: Bao Rui, Chen Lu, Luo Yukun, Zhang Mingbo
Published: (2025-03-01)

Primary liver lymphoma: review of the literature and clinical case presentation
by: A. K. Smolyaninova, et al.
Published: (2018-08-01)

Efficacy of parenteral pantoprazole in patients with acute ulcerative gastroduodenal bleeding at high risk of relapse
by: S. G. Shapovalyants, et al.
Published: (2012-04-01)

LOW-CEMENT DOSAGE REFRACTORY CONCRETE WITH LOW THERMAL CONDUCTIVITY
by: LUCIAN PAUNESCU, et al.
Published: (2023-02-01)

Effectiveness of dupilumab treatment against refractory eosinophilic chronic rhinosinusitis
by: Daiki Nakashima, MD, et al.
Published: (2025-05-01)

Treatment Patterns of Follicular Lymphoma in the United States: A Claims Analysis
by: Scott F. Huntington, et al.
Published: (2022-10-01)

Diagnosing MALT Gastric Lymphoma in Gastroenterologist’s Practice, a Clinical Observation
by: E. Ya. Selezneva, et al.
Published: (2021-10-01)

Erectile dysfunction in male lymphoma survivors in a Southeast Asian country
by: Gin Gin Gan, et al.
Published: (2022-07-01)

Continuously relapsing (for two years) course of diarrheal variant of IBS (<i>Clinical case</i>)
by: Ye. A. Poluektova, et al.
Published: (2013-10-01)

The utilization of the multimodal immunotherapy for the opsoclonus–myoclonus syndrome can reduce relapses and permanent neurological sequelae
by: Fang He, et al.
Published: (2025-02-01)

Panitumumab versus cetuximab in combination with irinotecan in refractory metastatic colorectal cancer
by: Maria Ignez Freitas Melro Braghiroli, et al.
Published: (2024-01-01)

Treatment Patterns and Health Care Costs in Commercially Insured Patients with Follicular Lymphoma
by: Nathan H. Fowler, et al.
Published: (2020-09-01)

Isolated central nervous system relapse in blast crisis of chronic myeloid leukemia: a case report
by: Hari Priya Raghvan, et al.
Published: (2025-01-01)

New opinion on the issue of proton pump inhibitor-refractory gastroesophageal reflux disease
by: Yu. V. Yevsyutina, et al.
Published: (2014-11-01)

The refractory form of gastroesophageal reflux disease: clinical and endoscopical, functional and morphofunctional criteria
by: M. A. Osadchuk, et al.
Published: (2011-03-01)

Microstructures, properties and preparations of lightweight refractory high-entropy alloys: A review
by: Gengchen Li, et al.
Published: (2025-03-01)

Extranodal Lymphomas as an Unusual Presentation in Usual Sites: A Potential Clinicoradiological Mimicker of Infection
by: R. Aruna Geethanjali, et al.
Published: (2025-01-01)

B-cell non-Hodgkin's lymphoma in the patient with chronic hepatitis C and mixed cryoglobulinemia
by: V. S. Adonyeva, et al.
Published: (2015-03-01)

A unique case of extranodal marginal zone lymphoma with synchronous pulmonary and dermatologic manifestations
by: Carlo Arevalo, et al.
Published: (2025-01-01)

BCL6 (B-cell lymphoma 6) expression in adenomyosis, leiomyomas and normal myometrium.
by: Loreta Canivilo Salas, et al.
Published: (2025-01-01)

Efficacy of parenteral rabeprazole at acute ulcer gastroduodenal bleeding in patients with high risk of relapse after endoscopic hemostasis
by: S. G. Shapovalyants, et al.
Published: (2014-09-01)

Lack of Tissue Virological Response as a Predictor of Relapse in Chronic Hepatitis D after Completion Bulevirtide Therapy
by: P. O. Bogomolov, et al.
Published: (2024-12-01)

Hillslope materials and processes /
by: Selby, Michael John
Published: (1982)